Abstract:Various heteroaryl and bicyclo-aliphatic analogues of zwitterionic biaryl P2Y14 receptor (P2Y14R) antagonists were synthesized, and affinity was measured in P2Y14R-expressing Chinese hamster ovary cells by flow cytometry. Given this series' low water solubility, various polyethylene glycol derivatives of the distally binding piperidin-4-yl moiety of moderate affinity were synthesized. Rotation of previously identified 1,2,3-triazole attached to the central m-benzoic acid core (25) provided moderate affinity but not indole and benzimidazole substitution of the aryl-triazole. The corresponding P2Y14R region is predicted by homology modeling as a deep, sterically limited hydrophobic pocket, with the outward pointing piperidine moiety being the most flexible. Bicyclic-substituted piperidine ring derivatives of naphthalene antagonist 1, e.g., quinuclidine 17 (MRS4608, IC50 ≈ 20 nM at hP2Y14R/mP2Y14R), or of triazole 2, preserved affinity. Potent antagonists 1, 7a, 17, and 23 (10 mg/kg) protected in an ovalbumin/Aspergillus mouse asthma model, and PEG conjugate 12 reduced chronic pain. Thus, we expanded P2Y14R antagonist structure–activity relationship, introducing diverse physical–chemical properties.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00745?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00745</a>.Synthesis of additional compounds (4-bromophenyl intermediates and carboxylate substitutions on the central phenyl ring of 2); off-target binding inhibition curves; pharmacological data; molecular modeling data, including docking poses of selected compounds, number of contacts between the receptor residues and the ligand in each MD replicate, RMSD and ligand–receptor interaction pattern during MD replicate 3, RMSD and ligand-receptor interaction pattern during MD replicate 4, and analysis of MD replicates; predicted pharmacokinetic parameters; predicted log D and log S; and methods to measure solubility and lipohilicity (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_001.pdf">PDF</a>)NMR and mass spectra of final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_006.pdf">PDF</a>)3D coordinates of hP2Y14R in complex with 17, obtained through molecular docking (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_002.pdb">PDB</a>)MD trajectory (replicate 3) of the complex between compound 17 and hP2Y14R, after alignment of the receptor Cα atoms to the initial frame (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_003.mp4">MP4</a>)MD trajectory (replicate 4) of the complex between compound 17 and hP2Y14R, after alignment of the receptor Cα atoms to the initial frame (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_004.mp4">MP4</a>)Molecular formula strings of P2Y14R antagonists (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_005.pdf">PDF</a>)This article has not yet been cited by other publications.

Structure-Based Virtual Screening for Discovery of Paederosidic Acid from Paederia Scandens As Novel P2Y14R Antagonist

Structure-based virtual screening for discovery of paederosidic acid from Paederia scandens as novel P2Y 14 R antagonist

Discovery of Novel and Potent P2Y14R Antagonists Via Structure-Based Virtual Screening for the Treatment of Acute Gouty Arthritis

Discover Natural Compounds As Potential Phosphodiesterase-4B Inhibitors Via Computational Approaches

Discovery and Computational Studies of 2-Phenyl-benzoxazole Acetamide Derivatives As Promising P2Y14R Antagonists with Anti-Gout Potential

Design of Group IIA Secreted/Synovial Phospholipase A2 Inhibitors: an Oxadiazolone Derivative Suppresses Chondrocyte Prostaglandin E2 Secretion

Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects

Design, Synthesis and Evaluation of 3-Amide-5-aryl Benzoic Acid Derivatives As Novel P2Y14R Antagonists with Potential High Efficiency Against Acute Gouty Arthritis.

Design, Synthesis and Anti-Inflammatory Evaluation of 3-Amide Benzoic Acid Derivatives As Novel P2Y14 Receptor Antagonists.

Identification of novel natural compound inhibitors for human complement component 5a receptor by homology modeling and virtual screening

Discovery of Novel and Selective Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease Through Comparative Structure-Based Virtual Screening

From lead to clinic: A review of the structural design of P2X7R antagonists

Harnessing marine natural products to inhibit PAD4 triple mutant: A structure-based virtual screening approach for rheumatoid arthritis therapy

Deapi-platycodin D3 attenuates osteoarthritis development via suppression of PTP1B

QSAR, structure-based pharmacophore modelling and biological evaluation of novel platelet ADP receptor (P2Y12) antagonist

Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in Osteoarthritis

Exploration of Alternative Scaffolds for P2Y 14 Receptor Antagonists Containing a Biaryl Core

The Rational Search for PDE10A Inhibitors from Sophoraï¿½flavescens Roots Using Pharmacophore‑ and Docking‑based Virtual Screening

Spermidine attenuates chondrocyte inflammation and cellular pyroptosis through the AhR/NF-κB axis and the NLRP3/caspase-1/GSDMD pathway

The rational search for PDE10A inhibitors from Sophora flavescens roots using pharmacophore‑ and docking‑based virtual screening.

Discovery of N-Substituted Acetamide Derivatives as Promising P2Y 14 R Antagonists Using Molecular Hybridization Based on Crystallographic Overlay